Group structure
6 companies in 3 countries
France1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading…
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
23 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ASN-CEPHALEXIN125 mg / 5 ml · Powder For Suspension | Cefalexin | Canada | Authorised | |
| ASN-CEPHALEXIN250 mg / 5 ml · Powder For Suspension | Cefalexin | Canada | Authorised | |
| ASN-DRONEDARONE400 mg · Tablet | Dronedarone | Canada | Authorised | |
| ASN-FINGOLIMOD0.5 mg · Capsule | Fingolimod | Canada | Authorised | |
| ASN-HYDRALAZINE10 mg · Tablet | Hydralazine | Canada | Authorised | |
| ASN-HYDRALAZINE25 mg · Tablet | Hydralazine | Canada | Authorised | |
| ASN-HYDRALAZINE50 mg · Tablet | Hydralazine | Canada | Authorised | |
| ASN-RASAGILINE0.5 mg · Tablet | Rasagiline | Canada | Authorised | |
| ASN-RASAGILINE1 mg · Tablet | Rasagiline | Canada | Authorised | |
| Denosumab Ascend 120 mg oplossing voor injectieOplossing voor injectie | Denosumab | Netherlands | Authorised | 2026 |
| ESTROGEL0.06% (1.25gm/activation) · Gel, metered | Estradiol | United States | Marketed | 2004 |
| ESTROGEL0.06% · GEL | Estradiol | United States | Not marketed | 2004 |
| Fampridine Ascend 10 mg tabletten met verlengde afgifteTablet met verlengde afgifte | Fampridine | Netherlands | Authorised | 2025 |
| Itraconazol Ascend 100 mg, harde capsulesCapsule, hard | Itraconazole | Netherlands | Authorised | 2025 |
| Rivaroxaban Ascend 10 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2025 |
| Rivaroxaban Ascend 15 mg + 20 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2025 |
| Rivaroxaban Ascend 15 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2025 |
| Rivaroxaban Ascend 2,5 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2025 |
| Rivaroxaban Ascend 20 mg filmomhulde tablettenFilmomhulde tablet | Rivaroxaban | Netherlands | Authorised | 2025 |
| Tizanidine Ascend 2 mg tablettenTablet | Tizanidine | Netherlands | Authorised | 2025 |
| Tizanidine Ascend 4 mg tablettenTablet | Tizanidine | Netherlands | Authorised | 2025 |
| Tizanidine Ascend 6 mg tablettenTablet | Tizanidine | Netherlands | Authorised | 2025 |
| Teriparatide Ascend | Teriparatide | EU (EMA) | Refused |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 11 | 11 | 0 | CompaniesAll medicines |
| Canada | 9 | 9 | 0 | CompaniesAll medicines |
| United States | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Colombia, Malaysia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Report an error or request removalCorrections from the company itself are welcome.
Keep Ascend’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)